Literature DB >> 4415734

Sequestration of macrophages in growing tumours and its effect on the immunological capacity of the host.

S A Eccles, P Alexander.   

Abstract

The effects of rat tumours of various macrophage contents on the syngeneic host's ability to produce either: (1) an inflammatory exudate in response to intraperitoneal oyster glycogen or (2) a cutaneous delayed hypersensitivity (DHS) response to PPD or SRBC after appropriate sensitization, were studied as a function of tumour growth.Both these reactions were found to be markedly decreased as the tumours grew. The suppression was greatest in animals bearing tumours of high macrophage content. The suppression of the DHS response could be reversed by a local injection of normal peritoneal macrophages with the eliciting antigen, and lymphocytes from tumour bearing animals exhibiting poor DHS responses were able to adoptively transfer DHS reactivity to normal unsensitized recipients. The monocyte infiltration in response to oyster glycogen was also decreased, and these data indicate a monocyte, rather than a lymphocyte defect in the tumour induced "anergy" in this system.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4415734      PMCID: PMC2009196          DOI: 10.1038/bjc.1974.111

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  13 in total

1.  Tumor immunity: impairment in tumor-bearing hosts.

Authors:  I D Bernstein; H T Wepsic; B Zbar; H J Rapp
Journal:  J Natl Cancer Inst       Date:  1971-04       Impact factor: 13.506

2.  The cellular immune response to primary sarcomata in rats. II. Abnormal responses of nodes draining the tumour.

Authors:  P Alexander; J Bensted; E J Delorme; J G Hall; J Hodgett
Journal:  Proc R Soc Lond B Biol Sci       Date:  1969-11-18

3.  Recovery of delayed-type hypersensitivity in mice following suppressive doses of X-radiation.

Authors:  A Volkman; F M Collins
Journal:  J Immunol       Date:  1968-11       Impact factor: 5.422

4.  Macrophages in syngeneic animal tumours.

Authors:  R Evans
Journal:  Transplantation       Date:  1972-10       Impact factor: 4.939

5.  The immunologic status of patients with nonlymphomatous cancer.

Authors:  C M Southam
Journal:  Cancer Res       Date:  1968-07       Impact factor: 12.701

6.  The origin of the mononuclear cells in inflammatory exudates induced by fibrinogen.

Authors:  W G Spector; M N Walters; D A Willoughby
Journal:  J Pathol Bacteriol       Date:  1965-07

7.  The relationship of delayed hypersensitivity to acquired antituberculous immunity. I. Tuberculin sensitivity and resistance to reinfection in BCG-vaccinated mice.

Authors:  F M Collins; G B Mackaness
Journal:  Cell Immunol       Date:  1970-09       Impact factor: 4.868

8.  Bone marrow as a source of cells in reactions of cellular hypersensitivity. I. Passive transfer of tuberculin sensitivity in syngeneic systems.

Authors:  D M Lubaroff; B H Waksman
Journal:  J Exp Med       Date:  1968-12-01       Impact factor: 14.307

9.  Immune response in tumor-bearing patients and animals. II. Incidence of tuberculin anergy in cancer patients.

Authors:  K Ashikawa; K Motoya; M Sekiguchi; Y Ishibashi
Journal:  Gan       Date:  1967-12

10.  The origin and kinetics of mononuclear phagocytes.

Authors:  R van Furth; Z A Cohn
Journal:  J Exp Med       Date:  1968-09-01       Impact factor: 14.307

View more
  15 in total

1.  Nutritional status and the nonspecific cellular and humoral immune response in esophageal carcinoma.

Authors:  A A Haffejee; I B Angorn
Journal:  Ann Surg       Date:  1979-04       Impact factor: 12.969

Review 2.  Effects of tumor growth on host defenses.

Authors:  G J Cianciolo; R Snyderman
Journal:  Cancer Metastasis Rev       Date:  1986       Impact factor: 9.264

Review 3.  Macrophages and neoplasms: new insights and their implication in tumor immunobiology.

Authors:  R Evans
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

4.  Tumour related inhibition of macrophage chemotaxis in patients with colon cancer.

Authors:  A Hermanowicz; P R Gibson; D P Jewell
Journal:  Gut       Date:  1987-04       Impact factor: 23.059

5.  Deficient strongly adherent monocytes in the peripheral blood of cancer patients.

Authors:  E M Hersh; C Gschwind; D L Morris; S Murphy
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

6.  Fc receptor-bearing and phagocytic cells in syngeneic tumours of C. parvum- and carrageenan-treated mice.

Authors:  A W Thomson; N Cruickshank; E F Fowler
Journal:  Br J Cancer       Date:  1979-05       Impact factor: 7.640

7.  Monocytosis associated with the growth of transplanted syngeneic rat sarcomata differing in immunogenicity.

Authors:  S A Eccles; G Bandlow; P Alexander
Journal:  Br J Cancer       Date:  1976-07       Impact factor: 7.640

8.  Suppression of in vitro cytotoxic response by macrophages due to induced arginase.

Authors:  J T Kung; S B Brooks; J P Jakway; L L Leonard; D W Talmage
Journal:  J Exp Med       Date:  1977-09-01       Impact factor: 14.307

9.  Suppression of macrophage oxidative metabolism by products of malignant and nonmalignant cells.

Authors:  A Szuro-Sudol; C F Nathan
Journal:  J Exp Med       Date:  1982-10-01       Impact factor: 14.307

10.  Inhibition of phagocytosis and glucose metabolism of alveolar macrophages during pulmonary tumour growth.

Authors:  P W Gudewicz; T M Saba
Journal:  Br J Cancer       Date:  1977-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.